A Randomized, Double Blind, Placebo-Controlled Trial of Alendronate Treatment for Fibrous Dysplasia of Bone

CONTEXT: Fibrous dysplasia (FD) is a rare skeletal disorder, resulting in deformity, fracture, functional impairment, and pain. Bisphosphonates have been advocated as a potential treatment. OBJECTIVE: To determine the efficacy of alendronate for treatment of FD. DESIGN: Two-year randomized, double-b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Endocrinol Metab
Autores principales: Boyce, Alison M., Kelly, Marilyn H., Brillante, Beth A., Kushner, Harvey, Wientroub, Shlomo, Riminucci, Mara, Bianco, Paolo, Robey, Pamela G., Collins, Michael T.
Formato: Artigo
Lenguaje:Inglês
Publicado: Endocrine Society 2014
Materias:
Endocrine Care
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4223439/
https://ncbi.nlm.nih.gov/pubmed/25033066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-1371
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares